Changing the class of NSAID in cases of hepatotoxicity.

NK assay using flow cytometry. J Immunol Methods 1986; 86: 7-15. 7 Abo T, Balch C M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 1981; 127: 1024-9. 8 Lanier L L, Le A M, Phillips J H, Warner N L, Babcock G F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 1983; 131: 1789-96. 9 Armstrong R D, Panayi G S. Natural killer cell activity in inflammatory joint disease. Clin Rheumatol 1983; 2: 243-9. 10 Thoen J, Forre 0, Pahle J. NK cells in rheumatoid arthritis and seronegative arthritis [Abstract]. Clin Exp Rheumatol 1987; 5 (suppl 2): 133. 11 Vinje 0, Forre 0, Degre M, Moller P. Natural killer cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis). Scand J Rheumatol 1984; 13: 297-302. 12 Combe B, Pope R, Darnell B, Talal N. Modulation of natural killer cell activity in the rheumatoid joint and peripheral blood. Scand J Immunol 1984; 20: 551-8. 13 Gonik B, Loo L S, Bigelow R, Kohl S. Influence of naproxen therapy on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus. J Reprod Med 1984; 29: 722-6. 14 Kohl S, Jansen D M, Loo L S. Indomethacin enhancement of human natural killer cytotoxicity to herpes simplex virus infected cells in vitro and in vivo. Prostaglandins Leukotrienes Med 1982; 9: 159-66. 15 Lala P K, Parhar R S, Singh P. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastases. Cell Immunol 1986; 99: 108-18.